Compare ACB & ACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACB | ACH |
|---|---|---|
| Founded | 2013 | 1882 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.3M | 217.5M |
| IPO Year | 2016 | 2000 |
| Metric | ACB | ACH |
|---|---|---|
| Price | $3.94 | $1.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.38 |
| AVG Volume (30 Days) | 1.7M | ★ 1.9M |
| Earning Date | 06-17-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,762,032,000.00 |
| Revenue This Year | $6.31 | N/A |
| Revenue Next Year | N/A | $4.43 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.56 | $0.93 |
| 52 Week High | $6.67 | $4.69 |
| Indicator | ACB | ACH |
|---|---|---|
| Relative Strength Index (RSI) | 73.07 | 28.80 |
| Support Level | $3.22 | $0.93 |
| Resistance Level | $4.15 | $2.65 |
| Average True Range (ATR) | 0.18 | 0.26 |
| MACD | 0.08 | -0.08 |
| Stochastic Oscillator | 99.21 | 9.57 |
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.